Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center study

Table 3 Predictive performance of the different prediction models

Prediction models	AUC (95%CI)	DeLong P value	Sensitivity (%)	Specificity (%)
Clinical Model 1 (BMI, HbA1c, FPG, 2hG)	0.783 (0.733-0.834)	0.736	72.78	73.72
Clinical Model 2 (BMI, HbA1c, FPG, TG1)	0.729 (0.673-0.784)	0.027	61.15	75.00
‘B3A’ Model [BMI and 3 biomarkers (HbA1c, GA, 1,5-AG)]	0.793 (0.744-0.843)	Reference	77.22	72.44

¹Natural-log transformed before analysis.

BMI: Body mass index; FPG: Fasting plasma glucose; HbA1c: Glycated hemoglobin; 1:5-AG: 1:5-anhydroglucitol; GA: Glycated albumin; TG: Triglyceride; AUC: Area under the receiver operating characteristic curve; 2hG: 2-hour glucose.